|

Red Light Therapy for Pain: How Photobiomodulation Reduces Inflammation

Red Light Therapy for Pain

At a Glance

  • How it works: Red and near-infrared light stimulate cytochrome c oxidase in mitochondria, boosting ATP production and reducing oxidative stress
  • Best wavelengths for pain: 630-670 nm (red) and 810-850 nm (near-infrared)
  • Conditions studied: Osteoarthritis, low back pain, neck pain, neuropathy, fibromyalgia, tendinopathy
  • Treatment time: Typically 10-20 minutes per session, 3-5 times per week
  • Safety: Extremely well-tolerated with virtually no serious side effects reported

What Is Photobiomodulation?

Photobiomodulation (PBM), commonly called red light therapy or low-level laser therapy (LLLT), uses specific wavelengths of red and near-infrared light to trigger biological changes at the cellular level. Unlike heat therapy or UV light, PBM works through a photochemical reaction, similar to how plants convert sunlight into energy through photosynthesis.

The technology has been studied since the 1960s, but the last decade has produced a surge of clinical research. For people living with chronic pain, the evidence base is becoming difficult to ignore. For a broader overview of this therapy, visit our red light therapy guide.

The Mechanism: How Light Reduces Pain and Inflammation

Cytochrome C Oxidase and ATP Production

The primary target of red and near-infrared light is cytochrome c oxidase (CCO), a photosensitive enzyme in the mitochondrial electron transport chain. When photons of the right wavelength hit CCO, they displace nitric oxide (NO) that has bound to the enzyme and is inhibiting its function. This displacement allows the enzyme to resume normal activity, increasing oxygen consumption and ATP production.

Stay ahead of the science

Get the latest regenerative medicine research, treatment guides, and clinic insights delivered weekly. No spam, unsubscribe anytime.

By subscribing you agree to receive emails from us. Unsubscribe anytime.

More ATP means more cellular energy for repair, reduced oxidative stress, and improved cell signaling. In damaged or inflamed tissue, mitochondrial function is often compromised. PBM essentially gives struggling cells an energy boost when they need it most.

Nitric Oxide Release

The nitric oxide displaced from CCO does not go to waste. Once freed, NO acts as a local vasodilator, increasing blood flow to the treated area. This improved circulation delivers more oxygen and nutrients while clearing inflammatory waste products. The vasodilatory effect also contributes to pain relief by reducing tissue pressure and ischemia.

Anti-Inflammatory Cascade

PBM reduces several key inflammatory mediators:

  • Decreased prostaglandin E2 (PGE2)
  • Reduced interleukin-1 beta (IL-1β) and tumor necrosis factor alpha (TNF-α)
  • Lower cyclooxygenase-2 (COX-2) expression
  • Increased anti-inflammatory cytokines like IL-10

This is essentially the same inflammatory pathway targeted by NSAIDs, but without the gastrointestinal side effects, kidney stress, or cardiovascular risk.

Why Wavelength Matters
Not all light is equal. Shorter wavelengths (red, 630-670 nm) penetrate about 1-2 cm into tissue, making them effective for superficial conditions. Longer wavelengths (near-infrared, 810-850 nm) penetrate 3-5 cm or more, reaching deeper joints, muscles, and nerves. Most pain conditions benefit from near-infrared or a combination of both.

Wavelengths and Dosing Parameters

ParameterRed LightNear-Infrared
Wavelength630-670 nm810-850 nm
Penetration depth1-2 cm3-5+ cm
Best forSkin, superficial wounds, surface inflammationDeep joints, muscle, nerve pain
Typical dose (fluence)4-8 J/cm²6-12 J/cm²
Session duration8-15 minutes10-20 minutes

The concept of “dose” in PBM is measured in joules per square centimeter (J/cm²), called fluence. There is a biphasic dose response, sometimes called the Arndt-Schulz curve: too little light produces no effect, the right amount stimulates healing, and too much can actually inhibit recovery. More is not always better.

Conditions Where Red Light Therapy Shows Evidence for Pain Relief

Osteoarthritis

Osteoarthritis (OA) is one of the best-studied conditions for PBM. A 2019 meta-analysis in the Journal of Clinical Medicine reviewed 22 randomized controlled trials and found that PBM significantly reduced pain and improved function in knee OA. Near-infrared wavelengths (808-860 nm) performed particularly well, likely because they penetrate deeply enough to reach the joint space.

Typical protocols for knee OA use 810-850 nm at 4-8 J/cm² per point, treating multiple points around the knee, 3 times per week for 4-8 weeks.

Low Back Pain

Chronic low back pain affects hundreds of millions of people globally. Multiple RCTs have shown PBM can reduce pain intensity and disability scores. A 2015 Lancet systematic review of LLLT for neck and back pain found clinically significant pain reduction, with effects lasting weeks to months after treatment ended.

The deep paraspinal muscles respond well to near-infrared wavelengths. Treatments targeting the lumbar region at 810-850 nm, applied for 10-15 minutes per session, have shown the most consistent results.

Neuropathic Pain

Neuropathic pain, including diabetic peripheral neuropathy, postherpetic neuralgia, and carpal tunnel syndrome, responds to PBM through a different mechanism. Light appears to modulate nerve conduction velocity, reduce neuroinflammation, and promote nerve regeneration.

Carpal tunnel syndrome has particularly strong evidence. A 2017 meta-analysis found that LLLT significantly reduced pain and improved grip strength and functional status compared to placebo.

Fibromyalgia

Fibromyalgia involves widespread pain with a strong central sensitization component. Several RCTs have demonstrated that PBM can reduce tender point counts, pain scores, and fatigue in fibromyalgia patients. The mechanism likely involves both peripheral anti-inflammatory effects and central nervous system modulation through increased endorphin release and reduced neural inflammation.

Tendinopathy

Chronic tendon pain, whether Achilles tendinopathy, patellar tendinopathy, or lateral epicondylitis (tennis elbow), has good evidence for PBM. Light therapy promotes collagen synthesis, reduces inflammatory mediators within the tendon, and improves blood flow to these typically avascular tissues.

Evidence Strength by Condition

  • Strong evidence: Knee osteoarthritis, neck pain, carpal tunnel syndrome, tendinopathy
  • Moderate evidence: Low back pain, fibromyalgia, TMJ disorders
  • Emerging evidence: Peripheral neuropathy, post-surgical pain, complex regional pain syndrome

Clinical Dosing Protocols for Pain

Getting the dose right is critical. The biphasic response means both underdosing and overdosing will fail to produce results. Here are evidence-based starting points:

Joint pain (knee, hip, shoulder): 810-850 nm, 6-10 J/cm² per treatment point, 4-6 points around the joint, 3x/week for 4-8 weeks.

Back/neck pain: 810-850 nm, 4-8 J/cm², treat along the paraspinal muscles in 3-5 spots, 3-5x/week for 3-6 weeks.

Tendon injuries: 810 nm, 4-8 J/cm², applied directly over the tendon, daily for 2 weeks then 3x/week for 4 weeks.

Neuropathy: 810-850 nm, 4-8 J/cm², applied along the affected nerve path, 3x/week for 6-8 weeks.

Home Devices vs. Clinical-Grade Equipment

The home PBM market has exploded, but not all devices are equal. Clinical-grade lasers and LED panels deliver significantly more power density (measured in mW/cm²) than most consumer products. A device with low power density may require impractically long treatment times to achieve therapeutic doses.

When evaluating home devices, look for:

  • Stated wavelength(s) with third-party testing
  • Power density of at least 50-100 mW/cm² at the treatment surface
  • FDA clearance (Class II medical device) is a plus but not required for LED panels
  • Clear documentation of irradiance at specified distances

High-quality panel devices from reputable manufacturers can deliver therapeutic doses at home. Cheap devices with vague specifications are unlikely to produce meaningful results.

Safety and Contraindications

PBM is one of the safest therapeutic modalities available. Serious adverse events are essentially absent from the literature. That said, a few precautions apply:

  • Do not shine light directly into the eyes (near-infrared is invisible and can damage the retina)
  • Avoid treating directly over active cancerous tumors (theoretical concern about promoting tumor growth)
  • Use caution over the thyroid gland
  • Photosensitizing medications (tetracyclines, certain antipsychotics) may increase sensitivity

Frequently Asked Questions

How long before I notice pain relief from red light therapy?

Some people feel relief after the first session, particularly for acute inflammation. For chronic conditions, expect 2-4 weeks of consistent treatment before seeing meaningful improvement. Tissue remodeling and nerve recovery may take 6-8 weeks.

Can I use red light therapy alongside medications?

Yes. PBM has no known drug interactions aside from increased photosensitivity with certain medications. It is commonly used alongside NSAIDs, acetaminophen, and even opioids. Some patients are able to reduce their pain medication over time as PBM takes effect.

Is red light therapy the same as infrared saunas?

No. Infrared saunas use far-infrared wavelengths (3,000-10,000+ nm) that generate heat. PBM uses red (630-670 nm) and near-infrared (810-850 nm) that trigger a photochemical reaction. The mechanisms and therapeutic targets are different.

How often should I do treatments?

For active pain, 3-5 sessions per week is standard. Once pain is well-controlled, some people shift to 2-3 times per week for maintenance. Consistency matters more than session length.

Does it work through clothing?

No. Fabric, especially dark-colored material, blocks or absorbs the light. Treat bare skin for best results. The device should be held close to or in contact with the skin for maximum energy delivery.

Can red light therapy make pain worse?

Rarely. Some people experience a mild, temporary increase in symptoms during the first few sessions, sometimes called a “healing reaction.” This typically resolves within 1-2 treatments. If it does not, the dose may be too high.


Stay ahead of the science

Get the latest regenerative medicine research, treatment guides, and clinic insights delivered weekly. No spam, unsubscribe anytime.

By subscribing you agree to receive emails from us. Unsubscribe anytime.

Similar Posts

Leave a Reply

Your email address will not be published. Required fields are marked *